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Alcoholic liver disease (ALD) is caused by chronic alcohol abuse and is a serious health 
concern worldwide. ALD is characterized by steatosis, inflammation, fibrosis, which can 
progress to cirrhosis. It is generally considered that the pathogenesis of ALD is intimately 
related to oxidative stress, derived from reactive intermediates including acetaldehyde, 
increased NADH/NAD+ ratio and ROS generation [1-4] (Figure 1). An increased level of 
fatty acids and ROS may result in lipid peroxidation and increased production of 
inflammatory cytokines, which can contribute to liver injury and fibrosis. Autophagy plays 
important roles in mitigating ethanol-induced hepatocyte apoptosis and liver injury [5].
1. Autophagy Pathways and Regulations
Autophagy is an evolutionarily conserved cellular process essential for development, 
differentiation, homeostasis and survival [6, 7]. Autophagy (from the Greek, “auto” oneself, 
“phagy” to eat) refers to cellular degradation that involves the delivery of cytoplasmic cargo 
(macromolecules or organelles) to the lysosome. There are three types of autophagy, 
macroautophagy, microautophagy and chaperone-mediated autophagy, which differ in the 
way by which cargo is delivered to the lysosomes [8]. Macroautophagy is a process, in 
which cytosolic materials are sequestered by autophagosomes, which transport them to the 
lysosome for degradation. Macroautophagy can be activated by many signals and is perhaps 
the most active form of autophagy in terms of the turnover of the cytosolic materials.
The process of microautophagy includes direct engulfment of cytoplasmic cargo at a 
boundary membrane of the lysosome, which mediate both invagination and vesicle scission 
into the lumen of lysosomes [9]. Microautophagy is mainly defined in the yeast, but has 
been observed in mammalian cells [10]. Chaperone mediated autophagy (CMA) involves 
direct shuttling of specific proteins across the lysosomal membrane for degradation in the 
lumen [11]. All proteins internalized in lysosomes through CMA contain in their amino acid 
sequence a pentapeptide motif that is necessary and sufficient for their targeting to 
lysosomes. These sequences can be recognized by chaperone proteins.
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The cargo-carrying vesicular structure formed during autophagy is known as the 
autophagosome. The origin of the autophagosomal membrane is not quite clear. Various 
models have been proposed [12]. These include the model that the membrane is synthesized 
de novo and the model that the membrane is derived from pre-existing cellular membranes 
such as the endoplasmic reticulum (ER) [13, 14], the Golgi complex [15], the mitochondria 
[16] and the plasma membrane [17]. Recent studies suggest that the ER is the most plausible 
candidate for the initial membrane source and/or the platform for autophagosome formation 
following amino acid starvation [18]. Electron tomography studies have found evidence 
supporting the connection of initial autophagosomal membranes to the ER membrane [19, 
20]. An ER membrane structure, known as the omegosome and identified by the molecule 
DFCP1, seems to be a site where ER membranes may evolve into autophagosomal 
membranes [21]. In addition, ER-derived COPII-coated vesicles, which bud from a 
specialized domain of the ER called the ER exit site (ERES), are found to contribute to 
autophagosome formation [22]. COP II vesicles are generally transporter vesicles, migrating 
from ER to the Golgi. Consistently, the ER-Golgi intermediate compartment (ERGIC) has 
also been identified as the most efficient membrane substrate for LC3 lipidation by 
recruiting the key early autophagic factor Atg14 [15]. It has to be noted that other 
membranes could also contribute to autophagosome formation and/or maturation at the early 
or later phase of the process. This may be particularly meaningful in selective autophagy in 
which specific subcellular organelles are selectively targeted.
In the past decade, researchers have elucidated key molecular pathways that regulate 
autophagy. These pathways consist mainly of Atg (Autophagy) proteins [23]. In mammalian 
cells, initiation of autophagosome biogenesis requires the ULK complex and the autophagy-
specific Beclin 1 complex. The ULK complex is composed of ULK1 or ULK2 (the 
mammalian orthologue of yeast Atg1), FIP200, mAtg13 and Atg101, and is required for the 
activation of autophagy-specific Beclin 1 complex. The latter is composed of Beclin 1 (the 
mammalian orthologue of yeast Atg6), Atg14, and class III phosphatidylinositol-3-kinase 
(PI3KC3) subunits Vps34, and Vps15. Notably, Beclin 1 can also interact with UVRAG, 
which, together with Vps34 and Vps15, forms a separate complex distinct from the Atg14-
Beclin 1 complex [24, 25]. Atg14L-Beclin 1 complex is found mainly in ER, isolation 
membranes and autophagosome and is responsible for autophagy initiation, whereas 
UVRAG-Beclin 1 complex is mainly found in the later endosome/lysosome, which is more 
related to endosomal function [24-26]. The relative abundance of the two complexes could 
be different in different cells, of which the regulation is little known. Rubicon, another 
Beclin-1 interacting protein, can negatively regulate the autophagy function of the Beclin-1 
complex, perhaps by association only with the Beclin-1-UVRAG complex, thus shifting the 
balance between the Atg14L-Beclin-1 complex and the UVRAG-Beclin 1 complex [25, 26].
Both ULK complex and Atg14-Beclin1 complex are inhibited by mTORC1, but activated by 
AMPK in opposing ways [27, 28], thus responding to metabolic or environmental changes. 
The autophagosomal membrane expansion requires two ubiquitin-like conjugation systems, 
Atg12 conjugation to Atg5 and LC3 conjugation to phosphatidylethanolamine (PE) [29, 30]. 
Notably, the Atg5-Atg12-Atg16 complex is required for the efficient conjugation of LC3 to 
PE, thus acting like an E3 ligase functionally [31]. The conjugation of LC3 is required for 
the autophagosomal membrane to expand and to complete the formation of the vesicular 
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structure. The Atg5-Atg12-Atg16 complex disengages the membranes after LC3 is 
conjugated. These molecules are thus associated only with the early autophagosomal 
membrane and are considered as the early markers. LC3 remains on the autophagosomes 
and is considered as the general marker of autophagosomes from the early to the later stage 
[32].
After autophagosomes are formed, they migrate to where lysosomes are located and engaged 
in the fusion with the latter to form autolysosomes. The cytoskeleton seems to be involved in 
the movement of autophagosomes. Agents such as nocodazole, which are microtubule 
poisons, can block fusion of the autophagosome with the lysosome, perhaps by preventing 
the movement of autophagosomes. Recent findings have identified Syntaxin 17 (Stx17) as 
the autophagosomal SNARE required for fusion with the endosome/lysosome [33]. Stx17 
localizes to the outer membrane of completed autophagosomes, and interacts with SNAP-29 
and the endosomal/lysosomal SNARE family molecule, VAMP8. Once fused, the inner 
membrane of the autophagosome and the cytoplasm-derived materials contained in the 
autophagosome are degraded by lysosomal/vacuolar enzyme. Monomeric units of the 
digested macromolecules, such as amino acids, are exported to the cytosol for reuse.
2. Regulation of Autophagy by Metabolic and Stress Signals
Multiple stimuli can promote or inhibit autophagy via different mechanisms. Nutrient 
deprivation is one of the best known autophagy stimulators. Other autophagy inducers 
include ER stress, oxidative stress, and DNA damage [34]. The presence of extracellular 
nutrients (i.e, amino acids, fatty acid, and glucose) and growth factors (e.g., insulin and 
insulin-like growth factor) can inhibit autophagy. The Class I phosphatidylinositol 3-kinase 
and mTORC1 are major inhibitors of autophagy along the signaling pathways mediated by 
nutrients and growth factors [35]. AMPK, being a negative inhibitor of mTORC1, can also 
promote autophagy. It seems that AMPK is particularly responsive to glucose level, and is 
thus responsible for autophagy triggered by glucose-deprivation [36]. As discussed above, 
AMPK and mTORC1 can directly modulate ULK1 and Beclin 1 complex to regulate 
autophagy induction.
ER stress is another well-known autophagy inducer. The ER is a key compartment in the cell 
to facilitate folding of newly synthesized proteins. A number of factors can serve as ER 
stress stimuli, including expression of aggregate-prone proteins, glucose deprivation 
(resulting in reduced glycosylation and decreased energy for chaperone activity), hypoxia 
and oxidative stress (causing decreased disulfide bond formation), Ca2+ efflux from the ER 
and inhibition of the proteasome, all leading to the accumulation of unfolded proteins in the 
ER [37]. When the folding capacity of ER is exceeded, the unfolded protein response (UPR) 
is triggered. Mammalian UPR involves three distinct signaling pathways mediated byIRE1, 
ATF6 and PERK, respectively. UPR causes a general reduction of protein synthesis but 
activation of the transcription of a selective group of proteins to increase ER folding capacity 
and degradation of the unfolded or mis-folded proteins. The latter is mainly mediated by the 
proteasome, and the process is known as the ER-associated degradation (ERAD). 
Autophagy has also been shown to be important for the degradation of the misfolded 
proteins, particularly in the condition when the proteasome is suppressed [38-40]. This 
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process is also coined as ER-associated autophagy (ERAA). It seems that mTORC1 is 
eventually suppressed through the activation of UPR, thus contributing to autophagy 
activation [41].
3. Activation of autophagy by ethanol
Ethanol can activate hepatic autophagy in vivo and in cultured primary hepatocytes [5, 42, 
Sid, 2013 #15, 43]. This activation requires ethanol metabolism and can thus requires the 
activity of alcohol dehydrogenase and cytochrome P450 2E1 (CYP2E1) [5, Wu, 2012 #10, 
44, 45]. It seems that the metabolite, acetaldehyde, may be responsible for the autophagy 
activation [45]. Acetaldehyde is a pro-oxidant. Indeed, anti-oxidants, such as N-acetyl 
cysteine (NAC) [5, 44] can suppress ethanol-induced autophagy. Certainly, ethanol 
metabolism can lead to increased oxidative stress via several other mechanisms, including 
the change in NADH/NAD+ ratio and mitochondrial damage [1-4]. Notably, deletion of 
cyclophilin D, a major component of mitochondrial permeability transition pore, impaired 
ethanol-induced autophagy [46], possibly due to a reduction in permeability transition and 
thus reduced reactive oxygen species (ROS) generation.
Both suppression of mTORC1 [47], and activation of AMPK [43] could contribute to 
ethanol-induced autophagy under oxidative stress (Figure 1). Consistently, activation of 
autophagy by rapamycin could reduce ethanol-induced liver injury [5, 44, 48]. Recently, it 
has been shown that FoxO3a is activated during ethanol treatment, and is responsible for the 
transcription of several autophagy genes [49]. Ethanol treatment of FoxO3a-deficient mice 
resulted in enhanced liver injury and steatosis. Resveratrol is well known to inhibit ethanol-
induced liver injury and steatosis [50], and it can also activate autophagy via increased 
deacetylation of FoxO3a [49] and activation of SIRT1 [51]. Protection of ethanol-induced 
damage by globular adiponectin can also be mediated by its enhancement of autophagy via 
FoxO3a and AMPK [52].
It is likely that other mechanisms could contribute to autophagy activation as well (Figure 
1). Ethanol treatment can lead to proteasome inhibition and ER stress, both of which are 
known to be linked to autophagy activation [40]. Suppression of proteasome can cause 
compensatory activation of autophagy via ER stress-mediated UPR, in which the IRE-1 and 
JNK pathway are involved [39]. Indeed, proteasome activity is inversely correlated with 
autophagy activation in ethanol-treated cells [42]. Finally, metal elements, such as zinc, can 
also be critical for autophagy during ethanol exposure and under basal level in hepatoma cell 
lines [53]. Thus zinc addition in the medium stimulated autophagy. Ethanol treatment can 
change the expression of zinc transporters and metallothionein, thus activating autophagy.
4. Autophagy protects against ethanol-induced liver injury
Autophagy induced by ethanol serves as a protective mechanism [5, 42, 44, 48]. Suppression 
of autophagy with pharmacologic agents or small interfering RNAs against Atg7 
significantly increased hepatocyte apoptosis and liver injury [5, 42, 48]. How autophagy 
protective against liver injury is not fully understood, but it could involve selective 
degradation of damaged mitochondrial and/or lipids [47].
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Traditionally autophagy is viewed as a non-selective process under nutrient deprivation 
condition. The non-selective bulk degradation of cytoplasm and organelles by autophagy can 
provide the basic building materials to support anabolic metabolism during starvation. 
However, selective removal of specific organelles by autophagy has now been well 
recognized [54]. All major organelles could be specifically targeted by autophagy, including 
mitochondria (mitophagy), ribosomes (ribophagy), endoplasmic reticulum (ER-phagy), 
peroxisomes (pexophagy), and lipid droplets (lipophagy). The selective functions of 
autophagy indicate that it is important for maintaining cellular homeostasis by removing 
superfluous or injured organelles.
Selective autophagy can be important in ameliorating alcoholic liver disease (Figure 1). 
Autophagy induced by ethanol seems to be selective for damaged mitochondria and 
accumulated lipid droplets, but not long-lived proteins [5]. Mitochondrial damage is well 
defined in alcoholic liver disease [55]. Ethanol is mainly metabolized by the liver and liver 
mitochondria can be a primary target for alcohol toxicity. A major catabolic pathway of 
ethanol begins with alcohol dehydrogenase (ADH), which generates acetaldehyde. The latter 
is oxidized predominately by the mitochondrial aldehyde dehydrogenase. In both steps 
NADH was generated and is oxidized indirectly by mitochondrial electron transport system. 
The excessive amount of NADH and thus the reducing capacity in the mitochondrial 
electron transport system is thought to cause an increased leakage of mitochondrial reactive 
oxygen species (ROS), causing alcohol-induced oxidative stress. This has been shown to 
alter oxidative phosphorylation, mitochondrial proteome and mitochondrial dynamics. 
Mitochondrial fragmentation was observed in ethanol-treated hepatocytes [47]. Ethanol 
treatment also increased the sensitivity of mitochondrial permeability transition [46]. 
Mitochondrial DNA depletion was observed in livers of ethanol-fed mouse [56, 57]. Chronic 
ethanol consumption causes enhanced oxidative damage to mtDNA along with increased 
strand breakage, and other alterations in the structural integrity of mitochondrial DNA [58], 
which has been thought to cause ethanol-related liver pathology.
Mitophagy may be important to eliminate dysfunctional and potentially deleterious 
mitochondria. Ethanol-induced autophagy can selectively target to the damaged 
mitochondria as observed in both acute [47] and chronic [59] ethanol consumption. What is 
the mechanism of this selectivity has yet to be determined. It is possible that the PINK1-
Parkin signaling may be involved. Immunoelectron microscopic studies indicated that 
expression of PINK1 was increased in mitochondria from ethanol-treated rats [59]. In 
addition, ethanol-mediated oxidative stress can also cause the translocation of the inducible 
form of heme oxygenase-1(HO-1) to the mitochondria, which in turn increases the 
recruitment of LC3 to the mitochondria [60]. The recognition of the damaged mitochondria 
could be mediated by multiple mechanisms and elucidation of these mechanisms is one of 
the important future works.
Another major mechanism of autophagy against alcohol liver disease is the elimination of 
intracellular lipids. Autophagosomes can transport the content of lipid droplets to the 
lysosome, in which lipids are degraded by the lysosomal acid lipase. This process, known as 
lipophagy [61], is still far from a complete understanding. Nevertheless, lipophagy occurs in 
ethanol condition [47]. Colocalization of LC3 with lipid droplet can be demonstrated in vivo 
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and in vitro [5, 48, 62]. Hepatic TG level in alcoholic fatty liver disease models was reduced 
by activating autophagy, and was elevated when autophagy was inhibited [5, 48].
One of the main features of alcohol fatty liver disease is the excessive accumulation of fatty 
acids. Free fatty acids can be detrimental to hepatocytes. The esterified lipids are sequestered 
in lipid droplets (LD) and would be considered non-harmful, although de-esterification can 
occur, which would increase cellular free fatty acids level. Removal of lipid droplet may 
favor the equilibrium toward the esterification. Indeed, we found that when autophagy 
function was modulated by suppressive agents, such as chloroquine, or enhancing agents, 
such as rapamycin, the hepatic triglycerides level was increased or decreased, respectively, 
in both acute and chronic ALD models [48]. Notably, similar observations can be made in a 
HFD-induced non-alcoholic fatty liver disease (NAFLD) model [48], suggesting that a 
common mechanism of lipophagy is involved. The effect of these agents was specific to 
autophagy as it was confirmed with the use of specific siRNA to knock down autophagy 
genes [5].
The combined effects of lipophagy and mitophagy may eliminate both the source of ROS 
and a potential target of ROS, the lipid, which can amplify the oxidative stress. It is possible 
that mitophagy might be more important in ALD where mitochondrial injury seems to be 
more prominent, in comparison with the situation in NAFLD. Another piece of evidence to 
support this notion is that CYP2E1 plays an important role in the toxicity of ethanol and it 
has been found that autophagy can suppress several adverse effects of CYP2E1 [44, 63]. 
Thus autophagy can protect against CYP2E1-induced mitochondrial damage and ROS 
generation.
It would be interesting to compare the role of autophagy in other types of liver injury. The 
role of autophagy in removing damaged mitochondria and controlling oxidative stress is also 
thought to be important for ameliorating ischemia-reperfusion induced liver injury [64]. 
Specific removal of the insoluble mutant alpha-1 anti-trypsin by the autophagosome is 
considered to be the mechanism by which autophagy protects against liver injury in alpha1-
antitrypsin deficiency [65, 66]. In contrast to its protective role in above cases, autophagy 
can also be detrimental to the liver. Many types of liver injury are accompanied with fibrosis, 
which can depend on the activity of hepatic stellate cells (HSC). Autophagy is shown to be 
important for the activation of HSC in the injury caused by carbon tetrachloride or 
thioacetamide [67, 68]. Autophagy facilitates the degradation of lipids in HSC, which is 
required for HSC activation. Under these conditions, suppressing autophagy in HSC via cell-
specific Atg7 knockout resulted in attenuated fibrosis. It is thus important to dissect the 
different roles of autophagy in liver injury in order to better understand how this mechanism 
may be applied in clinical management.
5. Suppression of autophagy by ethanol
The effect of ethanol on autophagy may depend on the duration of ethanol treatment, the 
level of ethanol in diet, the way ethanol is administered and possibly other dietary or 
environmental factors. Acute ethanol treatment promotes autophagy. Chronic alcoholic 
treatment using the low fat Lieber-DeCarli model also showed an elevation of autophagy 
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when ethanol was given at a lower level (accounting for 29% of the caloric need), but signs 
of suppression when ethanol was given at a higher level (accounting for 36% of the caloric 
need) [48]. However, in both cases, suppression of autophagy exacerbated liver injury while 
enhancement of autophagy improved the condition.
Ethanol can cause many other cellular changes, including proteasome inhibition, lysosome 
inhibition, endoplasmic reticulum (ER) stress and accumulation of aggregated proteins 
[69-74], all of which can be associated with autophagy function (Figure 1). Early studies 
showed the rate of hepatic protein degradation in ethanol-fed animals declined significantly 
[75], which might be due to declines in both proteasome and autophagy function, 
contributing to the development of hepatomegaly and the development of Mallory-Denk 
body (MDB). MDB is a characteristic of alcoholic liver disease and is positive for ubiquitin 
and p62/SQSTM1, a condition found in protein aggregates, and is often seen in autophagy 
deficiency. SQSTM1 is able to polymerize via an N-terminal PB1 domain and can interact 
with ubiquitinated proteins via the C-terminal UBA domain. SQSTM1 can bind directly to 
LC3 via a specific sequence motif [76]. The protein is itself degraded by autophagy and may 
serve to link ubiquitinated proteins to the autophagosomal membranes to enable their 
degradation in the lysosome. The presence of MDB suggests decline in autophagy during 
chronic ethanol condition. Indeed, by augmenting autophagy using rapamycin, an mTORC1 
inhibitor, clearance of MDB can be achieved in a mouse model of MDB pathology [77].
Chronic alcoholic treatment could lead to decreases in both the number and the function of 
the lysosome, therefore reducing autophagic degradation [78]. On the other hand, the fusion 
of autophagosomes and lysosome could also be affected. This may be due to a number of 
factors, including a poor distribution of lysosomes at where autophagosomes locate [45] and 
change in lysosome membrane due to steatosis as observed in high fat diet induced 
autophagy inhibition [79].
6. Summary
It is quite evident that autophagy is critical in maintaining normal liver function and plays 
important roles in a variety of liver pathogenesis (Figure 1). Autophagy is an attractive 
therapeutic target. The benefits of autophagy in protecting against alcoholic liver disease 
suggest that it may be possible to pharmacologically elevate or restore autophagy function to 
improve the liver function. Indeed, applications of clinically available agents, such as 
rapamycin and carbamazepine (CBZ), in mouse models of ALD have demonstrated the 
anticipated benefits [48]. However, the complexity in the cellular composition of the liver 
and the diversity in the response of these cells to pathological or physiological stimuli may 
need a cell type-specific strategy for modulating autophagy function to achieve the 
beneficial effect.
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Figure 1. The activation and function of autophagy in alcoholic liver disease
Ethanol metabolism through alcohol dehydrogenase (ADH), and/or P450 CYP2E1 results in 
an increased amount of acetaldehyde, an increased NADH/NAD+ ratio and an increased 
production of reactive oxygen species (ROS). The oxidative stress is further enhanced with 
the accumulation of lipids and mitochondrial damage, which can cause additional 
production of ROS and lipid peroxidation. Chronic use of alcohol can also result in 
proteasome and lysosome inhibition, leading to ER stress and accumulation of SQSTM1/
p62-positive ubiquitinated aggregated proteins, known as Malory-Denk body (MDB). These 
pathological cellular changes contribute to the development of alcohol fatty liver disease. On 
the other hand, oxidative stress can activate autophagy by increased AMPK activity and 
decreased MTORC1 activity. Proteasome inhibition can also enhance autophagy via ER 
stress, although lysosome inhibition can suppress autophagy. Autophagy may protect the 
liver against ethanol-induced damage by removing MDB, lipids and damaged mitochondria. 
Pharmacological enhancement of autophagy could thus be an effective and feasible way to 
treat alcoholic liver disease.
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